CX Institutional’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.16M | Sell |
12,641
-675
| -5% | -$59.1K | 0.03% | 314 |
|
|
2026
Q1 | $1.14M | Sell |
13,316
-78,946
| -86% | -$7.04M | 0.03% | 320 |
|
|
2025
Q4 | $7.29M | Buy |
92,262
+15,983
| +21% | +$1.25M | 0.22% | 124 |
|
|
2025
Q3 | $6.1M | Buy |
76,279
+14,137
| +23% | +$1.21M | 0.19% | 132 |
|
|
2025
Q2 | $5.65M | Buy |
62,142
+2,856
| +5% | +$261K | 0.2% | 130 |
|
|
2025
Q1 | $5.55M | Buy |
59,286
+54,747
| +1,206% | +$4.9M | 0.21% | 114 |
|
|
2024
Q4 | $413K | Buy |
4,539
+340
| +8% | +$32.4K | 0.02% | 376 |
|
|
2024
Q3 | $436K | Sell |
4,199
-216
| -5% | -$22K | 0.02% | 387 |
|
|
2024
Q2 | $428K | Sell |
4,415
-21
| -0.5% | -$1.94K | 0.02% | 387 |
|
|
2024
Q1 | $399K | Buy |
4,436
+20
| +0.5% | +$1.7K | 0.02% | 400 |
|
|
2023
Q4 | $352K | Sell |
4,416
-2,236
| -34% | -$168K | 0.02% | 375 |
|
|
2023
Q3 | $473K | Buy |
6,652
+16
| +0.2% | +$1.2K | 0.03% | 335 |
|
|
2023
Q2 | $511K | Buy |
6,636
+327
| +5% | +$25.3K | 0.03% | 344 |
|
|
2023
Q1 | $475K | Sell |
6,309
-43,048
| -87% | -$3.2M | 0.03% | 351 |
|
|
2022
Q4 | $3.89M | Buy |
+49,357
| New | +$3.7M | 0.24% | 116 |
|
|
2022
Q3 | – | Sell |
-11,589
| Closed | -$929K | – | 579 |
|
|
2022
Q2 | $929K | Buy |
11,589
+2,943
| +34% | +$230K | 0.07% | 247 |
|
|
2022
Q1 | $656K | Sell |
8,646
-35,300
| -80% | -$2.8M | 0.05% | 254 |
|
|
2021
Q4 | $3.75M | Buy |
43,946
+19,328
| +79% | +$1.51M | 0.3% | 102 |
|
|
2021
Q3 | $1.86M | Buy |
24,618
+201
| +0.8% | +$16K | 0.15% | 155 |
|
|
2021
Q2 | $1.99M | Buy |
24,417
+741
| +3% | +$60.6K | 0.16% | 154 |
|
|
2021
Q1 | $1.87M | Buy |
23,676
+22,029
| +1,338% | +$1.73M | 0.17% | 162 |
|
|
2020
Q4 | $141K | Sell |
1,647
-338
| -17% | -$27.9K | 0.01% | 318 |
|
|
2020
Q3 | $153K | Buy |
1,985
+615
| +45% | +$46.9K | 0.02% | 276 |
|
|
2020
Q2 | $100K | Buy |
1,370
+600
| +78% | +$42.6K | 0.01% | 290 |
|
|
2020
Q1 | $51K | Sell |
770
-117
| -13% | -$8.25K | 0.01% | 310 |
|
|
2019
Q4 | $61K | Sell |
887
-581
| -40% | -$39.6K | 0.01% | 266 |
|
|
2019
Q3 | $108K | Sell |
1,468
-148
| -9% | -$10.7K | 0.02% | 240 |
|
|
2019
Q2 | $116K | Sell |
1,616
-1,516
| -48% | -$108K | 0.02% | 259 |
|
|
2019
Q1 | $215K | Buy |
3,132
+2,978
| +1,934% | +$192K | 0.04% | 208 |
|
|
2018
Q4 | $9K | Buy |
+154
| New | +$9.63K | ﹤0.01% | 357 |
|
Other funds holding CL
CX Institutional's CL Position: Q2 2026 in Review
CX Institutional reduced its Colgate-Palmolive (CL) stake by 5.1% in Q2 2026, selling an estimated $59.1K and leaving 12,641 shares worth $1.16M. The position accounts for 0.03% of the portfolio, ranked #314.
CX Institutional first reported a position in CL in Q4 2018 and has held it in 30 quarters since. The position peaked at $7.29M in Q4 2025. 2,014 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- CX Institutional held 12,641 shares of Colgate-Palmolive worth $1.16M as of Q2 2026.
- CX Institutional sold 675 Colgate-Palmolive shares in Q2 2026, an estimated $59.1K.
- Colgate-Palmolive made up 0.03% of CX Institutional's portfolio in Q2 2026, its #314 holding.
- CX Institutional first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 30 quarters since.
- CX Institutional's Colgate-Palmolive position peaked at $7.29M in Q4 2025.
- 2,014 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.